Abstract
Diabetes mellitus is the only growing cause of end stage renal disease (ESRD) in all of the industrialized countries [1, 2, 3]. Approximately one quarter of all diabetic patients suffer from renal failure and many of them die of ESRD [4]. Despite this large number, fifteen years ago only a few diabetic patients were accepted for dialysis in Europe and the United States with poor results [5]. Today every one agrees that exclusion of diabetic patients from renal replacement therapy is no longer acceptable when the socio economic environment is adequate and treatment facilities are available [6, 7, 8]. Diabetic patients should be offered all dialysis methods and renal or renal and pancreas transplantation within an integrated program [9, 10, 11]. In some parts of the United States, the number of diabetic patients in the dialysis-transplant programs reaches 25 to 30% [7] and in Europe around 12% with great differences between the latin countries and the nordic countries [12, 13].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Avram MM: Diabetic renal failure Nephron 31: 285–290. 1982.
Friedman EA: Clinical imperatives in diabetic nephropathy. Kidney Int 23, (suppl) 14: S16-S19, 1982.
Friedman EA: Diabetic nephropathy. Strategies in prevention and managements. Kidney Int 21: 780–791, 1982.
Knowles HC: Magnitude of the renal failure problem in diabetic patients. Kidney Int 6. S1: 2–7, 1976.
Ghavanian M, Gutch CF, Kopp KF, Kolff WJ: The sad truth about hemodialysis in diabetic nephropathy. JAMA 222: 1386–1389, 1972.
Friedman EA: Overview of diabetic nephropathy. In: Keen H, Legrain M (eds), Prevention and Treatment of Diabetic Nephropathy. MTP, Lancaster,, pp. 3–19, 1983.
Friedman EA: Clinical strategy in diabetic nephropathy. In: E. Friedman et F. l’Esperance (eds), Diabetic Renal-Retinal Syndrome 3. Grune and Stratton, New York, 3: pp 331–337, 1986.
Legrain M: Diabetics with end stage renal disease: the best buy. Editorial. Diabetic Nephropathy 2: 1–3, 1983.
Legrain M, Gahl GM, Boudjemaa A, Rottembourg J: The case for dialysis in diabetics. Transplantation proceedings. 18, 6: 1693–1697, 1986.
Sutherland D, Fryd DS, Simmons RL, Ferguson RM, Najarian JS: Current status of kidney transplantation in uremic diabetics at the University of Minnesota. In: E. Friedman, F. l’Esperance. Diabetic Renal Retinal Syndrome 2 (eds), Grune and Stratton, New York, pp. 373–383, 1982.
Sutherland DER, Moudry K: Pancreas transplant registry report. Transplant Proc. 18, 6: 1747–1750, 1986.
Geerlings W, Broyer M, Brunner FP, Brynger H, Fassbinder W, Rizzoni G, Selwood HH, Tufveson G, Wing AJ: Combined report on regular dialysis and transplantation in Europe 1986. Nephr. Dial. Transpl. 2, 109–122, 1988.
Cameron JJ, Challah S: Treatment of end stage renal failure due to diabetes in the United Kingdom 1975–1984. Lancet 2: 962–966, 1986.
Belzer FO, Milper DT, Sollinger HW, Glass NR: Simplified kidney transplants in insulin dependant diabetics. In: Friedman E, l’Esperance F (eds), Diabetic Renal Retinal Syndrome 3. Grüne and Stratton, New York, pp 413–420, 1986.
Khauli RB, Steinmuller DR, Novick AC: A critical look at survival of diabetics with end stage renal disease: transplantation versus dialysis therapy. Transplantation 41: 598–601, 1986.
Jacobs C, Brunner F, Brynger H, Challah S, Kramer P, Selwood N, Wing A: The first five thousand diabetics treated by dialysis and transplantation in Europe. Diabetic Nephropathy 2: 11–16, 1983.
Kjellstrand C, Whitley K, Comty C, Shapiro F: Dialysis in patients with diabetes mellitus. Diabetic Nephropathy. 2:5–17, 1983.
Amair P, Khanna R, Leibel B, Pieratos A, Vas S, Meema E, Blair G, Chisholm L, Vas M, Zingg W, Dibenis G, Oreopoulos DG: Continuous ambulatory peritoneal dialysis in diabetics with end stage renal disease. N Eng J Med 306: 625–630, 1982.
Legrain M, Rottembourg J, Bentchikou A, Poignet JL, Issad B, Barthelemy A, Strippoli P: Dialysis treatment of insulin dependent diabetic patients. A ten years experience. Clinical Nephrology 21: 72–81, 1984.
Blumenkrantz M, Shapiro D, Mimura N, Oreopoulos DG: Maintenance peritoneal dialysis as an alternative in the patients with diabetes mellitus and end stage uremia. Kidney Int. 6 (Suppl 1): 108–114, 1974.
Rubin J, Oreopoulos DG, Blair RD, Chisholm LD, Meema HE, de Veber GA: Chronic peritoneal dialysis in the management of diabetics with terminal renal failure. Nephron 19: 265–270, 1977.
Lameire N, Dhaene M, Matthys E, de Paepe M, Vereerstraeten P, Dratwa M, Ringoir S: Experience with CAPD in diabetic patients. In: Keen H, Legrain M (eds), Prevention and Treatment of Diabetic Nephropathy. MTP Ltd. Lancaster, pp 289–297, 1983.
Polla-Imhoof B, Pirson Y, Lafontaine JJ, Vandenbroucke JM, Cosyns JP, Squifflet JP, Alexandre G, van Ypersele de Strihou C: Resultats de l’hémodialyse chronique et de la transplantation rénale dans le traitement de l’urémie terminale du diabétique. Néphrologie 3: 80–84, 1982.
Thomson NM, Simpson RW, Hooke D, Atkins RC: Peritoneal dialysis in the treatment of diabetic end stage renal failure. In: Atkins RC, Thomson NM, Farell PC. Peritoneal Dialysis (eds), Churchill Livingstone, New York, pp 345–355, 1981.
Khanna R, Wu G, Chisholm L, Oreopoulos D: Update: Further experience with CAPD in diabetics with end stage disease. Diabetic Nephropathy 2: 8–12, 1983.
Khanna R, Wu G, Prowant B, Jastrzebska J, Nolph KD, Oreopoulos DG: Continuous ambulatory peritoneal dialysis in diabetics with end stage renal disease: a combined experience of two North American centers. In: Friedman E, l’Esperance F (eds). Diabetic Renal Retinal Syndrome 3. Grüne and Stratton, New York, pp 363–381, 1986.
Rottembourg J: Le traitement de l’insuffisance rénale du diabétique. La Presse Med. 46: 437–440, 1987.
Shapiro FL: Haemodialysis in diabetic patients. In: H. Keen, M. Legrain (eds), Prevention and Treatment of Diabetic Nephropathy. MTP Ldt, Lancaster, pp 247–259, 1983.
Nolph KD, Cutler SJ, Steinberg SM, Novak JW: Continuous ambulatory peritoneal dialysis in the United States: A three year study. Kidney Int. 28: 198–205, 1985.
Zimmerman SW, Johnson CA, O’Brien M: Survival of diabetic patients on CAPD for over five years. Perit Dial Bull 7: 26–29, 1987.
Flynn CT: Long term continuous ambulatory peritoneal dialysis. Proc Europ Dial Transpl Ass 20: 700–704, 1983.
Flynn CT, Hibbard J, Dohrman B: Advantages of coninuous ambulatory peritoneal dialysis to the diabetic with renal failure. Proc Europ Dial Transpl Ass 16: 184–190, 1979.
Flynn CT: The diabetic on CAPD. In: Friedman E, L’Esperenace F (eds), Diabetic Renal Retinal Syndrome 2, Grüne and Stratton, New York, pp 320–330, 1982.
Madden MA, Zimmerman S, Simpson DP: Continuous ambulatory peritoneal dialysis in diabetes mellitus. Amer J Nephrol 2: 133–139, 1982.
Legrain M, El Shahat Y, Rottembourg J, Balducci A, Jacobs C: Continuous ambulatory peritoneal dialysis versus other treatment modalities in end stage diabetic nephropathy. In G Jahl, M Kessel, K Nolph (eds). Advances in Peritoneal Dialysis. Excerpta Medica, Amsterdam, pp 365–368, 1981.
Rottembourg J, El Shahat Y, Agrafiotis A, Thuillier Y, de Groc F, Jacobs C, Legrain M: Continuous ambulatory peritoneal dialysis in insulin dependent diabetics: a 40 months experience. Kidney Int. 23: 40–45, 1983.
Rottembourg J, Issad B, Poignet JL, Strippoli P, Balducci A, Slama G, Gahl G: Residual renal function and control of blood glucose levels in insulin-dependent diabetics patients treated by CAPD. In: Keen H, Legrain M (eds), Prevention and Treatment of Diabetic Nephropathy. MTP Ltd, Lancaster, pp 339–352, 1983.
Rottembourg J, de Groc F, Issad B, Mehamha H, Souid M, Abada S, Gahl GM: Continuous ambulatory peritoneal dialysis in insulin dependent diabetics: advantages and Shortcomings. In: Mackowa M, Nolph KD, Kishimoto T, Moncrief JW (eds), Machine free Dialysis for Patient Convenience. ISAO Press. Cleveland: pp 75–80, 1984.
Rottembourg J, Jacq D, Vonlanthen M, Issad B, El Shahat Y: Straight or curled Tenckhoff peritoneal catheter for continuous ambulatory peritoneal dialysis. Perit Dial Bull 1:123–124, 1981.
Rottembourg J, Quinton W, Durande JP, Brouard R: Wings as subcutaneous cuff in prevention of exit site infection in CAPD patients. Perit Dial Bull 7, S2: 63, 1987.
Twardowski ZJ, Khanna R, Nichols WK, Nolph KD, Prowant BF, Ryan LP, Russ J: Low complications rates with swan neck short tunnel Missouri peritoneal catheter. Perit Dial Bull 7, S2: 80, 1987.
Legrain M, Rottembourg J, Issad B, Cossette PY, Boudjemaa A: Continuous ambulatory peritoneal dialysis in diabetic patients. In IX Int. Congress of Nephrology. Los Angeles, Springer Verlag. New York, pp 1599–1610, 1984.
Oreopoulos DG, Baird-Helfrich G, Khanna R, Lum GM, Mathews R, Paulsen K, Twardowski ZJ, Vas SI: Peritoneal catheters and exit site. Pratices: current recommendations. Perit Dial Bull 7: 130–137, 1987.
Rottembourg J, Brouard R, Issad B, Allouache M, Jacobs C: Prospective randomized study about Y connectors in CAPD patients. In: Khanna R, Nolph KD, Prowant B, Twardowski ZJ, Oreopoulos DG (eds), Advances in Continuous Ambulatory Peritoneal Dialysis. Perit Dial Bull Inc Toronto, 7: pp 107–113, 1987.
Avram MM, Paik SK, Okanya D, Rajpal K: The natural history of diabetic nephropathy: unpredictable insulin requirements. A further clue. Clin Nephrol 21: 36–38, 1984.
Porte DJ, Bagdade JD: Human insulin secretion: an integrated approach. Ann Rev Med 21: 219–240, 1970.
Graber AL: Chronic peritoneal dialysis in insulin dependent diabetes mellitus — diabetic clinical care-conference. J Tenn Med Ass 2: 74–78, 1981.
Schade DS, Eaton RP, Spencer W: The advantages of peritoneal route of insulin delivery. In: Irsigler K, Kunz KN, Owen DR, Regal H (eds), New Approaches to Insulin Therapy, MTP Press Lancaster, pp 31–39, 1981.
Balducci A, Slama G, Rottembourg J, Baumelou A, Delage A: Intraperitoneal insulin in uraemic diabetics undergoing continuous ambulatory peritoneal dialysis. Brit Med J 283: 1021–1023, 1981.
Twardowski ZJ, Nolph KD, Mac Gary TJ, Moore HL, Collin P, Ausman RK, Slimack WS: Insulin binding to plastic bag: a methodologic study. Am J Hosp Pharm 40: 575–579, 1983.
Johnson CA: Adsorption of insulin to the surface of peritoneal dialysis solution containers. Am J Kidney Dis 3: 224–228, 1983.
Rottembourg J, Carayon A, Benoliel D, Peluso F, Ozanne P: Critical evaluation of the injection site for insulin in CAPD for diabetic patients. In: JF Maher and JF Winchester (eds), Frontiers in Peritoneal Dialysis; Fields, Rich and Ass. New York, pp 283–287, 1986.
Amidon G, Reicher J, Curtis SM, Johnson A: Absorption of insulin to the surface of polyvinyl CAPD solution containers. Proc Dial Transplant Forum 10: 296–301, 1980.
Wideroe TE, Sineby LC, Berg KJ: Intraperitoneal (1 125) insulin absorption during intermittent and continuous peritoneal dialysis. Kidney Int 23: 22–28, 1983.
Twardowski ZJ: Insulin adsorption to peritoneal dialysis bags. Perit Dial Bull 3: 113–115, 1983.
Khanna R, Oreopoulos DG: CAPD in patients with diabetes mellitus. In: Gokal R. Editor. Continuous Ambulatory Peritoneal Dialysis. Churchill Livingstone — Edinburgh, pp 291—305, 1986.
Carta Q, Monge L, Triolo G, Dani F, Salomone M, Vercellone A, Vitelli A: Continuous insulin infusion in the management of uremic diabetic patients on dialysis: clinical experience with subcutaneous and intra peritoneal delivery. Diabetic Nephropathy 4: 83–87, 1985.
Groop LC, van Bonsdorff MC: Intra peritoneal insulin administration does not promote insulin antibody production in insulin dependent diabetes mellitus patients on dialysis. Diabetic Nephropathy 4: 80–82, 1985.
Friedman EA, Levits C, Hirsch S, Butt K: Feasibility of self blood glucose monotoring in uremic diabetics. In: Friedman E, L’Esperance F (eds), Diabetic Renal Retinal Syndrome 2. Grüne and Stratton, New York, pp 437–445, 1982.
Graft RJ, Porte JD: Glycosylated haemoglobin as an index of glycemia independent of plasma insulin in normal and diabetic subjects. Diabetes 27: 368–372, 1977.
Gabbay K: Glycohaemoglobin. A measure of glycaemic cruising altitude. In: Keen H, Legrain M (eds), Prevention and Treatment of Diabetic Nephropathy. Lancaster, MTP Ltd, pp 145–153, 1983.
Boer MJ, Miedema K, Casparie AF: Glycosylated haemoglobin in renal failure. Diabetologia 18: 437–440, 1980.
Rottembourg J, Issad B, Gallego JL, Degoulet P, Aime F, Gueffaf B, Legrain M: Evolution of residual renal function in patients undergoing maintenance hemodialysis or continuous ambulatory peritoneal dialysis. Proc Europ Dial Transpl Ass 19: 397–401, 1982.
Mion C, Slingeneyer A, Canaud B, Oules R, Branger G, Chong G, Mourad G: Home intermittent peritoneal dialysis in the treatment of end-stage diabetic nephropathy. 1982 Update. In: Keen H and Legrain M (eds), Prevention and Treatment of Diabetic Nephropathy. Lancaster, MTP Ltd, pp 263–277, 1983.
Ahmads, Gallager N, Shen F: Intermittent peritoneal dialysis: Status reassessed. Trans Amer Soc Artif Intern Organs 25: 86–90, 1979.
Maiorca R, Cantaluppi A, Cancarini GC et al: Prospective controlled trial of a Y connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis. Lancet 2: 642–644, 1983.
Katirtzoglou A, Izatt S, Oreopoulos DG: Chronic peritoneal dialysis in diabetics with end stage renal failure. In: Friedman EA and L’Espereance F (eds), Diabetic Renal Retinal Syndrome 2. Grüne and Stratton, New York, pp 317–332, 1982.
Heaton A, Rodger ESC, Sellars L, Goodship THJ, Fletcher K, Nikolakakis N, Ward MK, Wilkinson R, Kerr DNS: Continuous ambulatory peritoneal dialysis after the honeymoon: review of experience in Newcastle 1979–1984. Br Med J 293: 938–941, 1986.
Maiorca R, Cancarini GC, Colombrita D: Further experience with Y system in continuous ambulatory peritoneal dialysis. In: Khanna R, Nolph KD, Prowant B, TWardowski ZT, Oreopoulos DG (eds), Advances in Continuous Ambulatory Peritoneal Dialysis 1986. Perit Dial Bull Inc Toronto, 6: pp 172–175, 1986.
Cantaluppi A, Scalamogna A, Castelnova C, Graziani G: Peritonitis prevention in CAPD. Long term efficacy of a Y connector and disinfectant. Perit Dial Bull 6: 58–61, 1986.
Faller B, Marichal JF: Loss of ultrafiltration in CAPD: clinical data. In: Gahl G, Kessel M, Nolph K (eds), Advances in Peritoneal Dialysis. Amsterdam, Excerpta Medica, 1981, pp 227–232.
Slingeneyer A, Canaud B, Mion C: Permanent loss of ultrafiltration capacity of the peritoneum in long term peritoneal dialysis: an epidemiological study. Nephron 33: 133–138, 1983.
Rottembourg J, Brouard R, Issad B, Allouache M, Ghali B, Boudjemaa A: Role of acetate in loss of ultrafiltration during CAPD. In: Berlyne GM, Giovannetti S (eds), Contribution to Nephrology. Karger-Basel 57: pp 197–206, 1987.
Rottembourg J, Gahl G, Poignet JL, Mertani E, Strippoli P, Langlois P, Tranbaloc P, Legrain M: Severe abdominal complications in patients undergoing continuous ambulatory peritoneal dialysis. Proc Europ Dial Transpl Ass 20: 236–242, 1983.
Slingeneyer A, Mion C, Mourad G, Canaud B, Faller B, Beraud JJ: Progressive sclerozing peritonitis: a late and severe complications of maintenance peritoneal dialysis. Trans Am Soc Art Int Organ 29: 633–640, 1983.
Norbeck H, Oro L, Carlson LA: Serum lipid and lipoprotein concentrations in chronic uremia. Act Med Scand 200: 487–495, 1976.
Gokal R, Ramos JM, McGurk JG, Ward MK, Kerr DNS: Hyperlipidaemia in patient on continuous ambulatory peritoneal dialysis. In: Gahl G, Kessel M, Nolph K (eds), Advances in Peritoneal Dialysis. Amsterdam, Excerpta Medica, pp. 430–433, 1981.
Moncrief JW, Pyle WK, Simon P, Popovich RP: Hypertriglyceridemia, diabetes mellitus and insulin administration in patients undergoing continuous ambulatory peritoneal dialysis. In: Moncrief J, Popovich R (eds), CAPD Update. Masson, Yew York, pp 143–165, 1981.
Norbeck H: Lipid abnormalities in continuous ambulatory peritoneal dialysis. In: Legrain M (eds), Continuous Ambulatory Peritoneal Dialysis. Excerpta Medica, Amsterdam, pp 298–301, 1979.
Beardsworth SF, Goldmith HJ, Stanbridge BR: Intraperitoneal insulin cannot correct the hyperlipidemia of CAPD. Perit Dial Bull 3: 126–128, 1983.
Dombros N, Oren A, Marliss EB, Anserson GH, Stern AN, Khanna R, Pehl J, Brades L, Roddella H, Labeil BS, Oreopoulos DG: Plasma amino acides profiles and amino acid losses in patients undergoing CAPD. Perit Dial Bull 2: 37–32, 1982.
Giordano C, De Santo NG, Capodicase G: Amino acid losses during CAPD. Clin Nephrol 14: 230–232, 1980.
Wu G: Osmotic agents for peritoneal dialysis solutions. Perit Dial Bull 2: 154–158, 1982.
Drouin JY, Jaudon MC, Guimont MC, Rottembourg J, Dubois M, Mollet M, Galli A, Legrain M: Le glucose doitil et peut-il être remplacé dans les solutés utilisés pour la dialyse péritonéale? Thérapie 42: 209–217, 1984.
Bazzato G, Coli U, Landini S, Frascasso A, Morachiello P, Riguetto F, Scanferla F: Xylitol and low dosages of insulin: new perspectives for diabetic uraemic patients on CAPD. Perit Dial Bull 2: 161–165, 1982.
De Paepe M, Matthys E, Peluso F, Dokart R, Lameire N: Experience with glycerol as the osmotic agent in peritoneal dialysis in diabetic and non diabetic patients. In Prevention and treatment of diabetic nephropathy. Eds Keen H, Legrain M, Lancaster, PTP Ltd, pp 299–311, 1983.
Matthys E, Dolkart R, Lameire N: Extended use of a glycerol-containing dialysate in diabetic CAPD patients. Perit Dial Bull 7: 10–19, 1987.
Matthys E, Dolkart R, Lameire N: Potential hazards of glycerol dialysate in diabetic CAPD patients. Perit Dial Bull 7: 16–19, 1987.
Daniels FH, Leohnard EF, Cortell S: Glucose and gycerol compared as osmotic agents for peritoneal dialysis. Kidney Int. 25: 20–25, 1984.
Oren A, Wu G, Anderson G, Marliss E, Khanna R, Petit J, Mupas L, Rodella H, Brandes L, Roncari D, Kakis G, Harrison J, Mc Neil K, Oreopoulos DG: Effective use of amino-acid dialysate over four weeks in CAPD patients. Amer Soc Art Int Organs 29: 604–610, 1983.
Schilling H, Wu G, Petit J, Mitwalli A, Anderson GH, Ogilvie R, Oeropoulos DG: Effects of prolonged CAPD with amino acid containing solutions in three patients. In: Khanna R, Nolph KD, Prowant B, Twardowski ZJ, Oreopoulos DG (eds), Advances in Continuous Ambulatory Peritoneal Dialysis. Perit Dial Bull Inc Toronto 5: pp 49–55, 1985.
Mistry CD, Mallick NP, Gokal R: The use of large molecular weight glucose polyper (MW 20.000) as an osmotic agent in continuous ambulatory peritoneal dialysis. Khanna R, Nolph KD, Prowant B, Twardowski Z, Oreopoulos DG (eds), Advances in Continuous Ambulatory Peritoneal Dialysis. Perit Dial Bull Inc Toronto, 6: pp 7–11, 1986.
Rottembourg J, Bellio P, Maiga K, Remaoun M, Rousselie F, Legrain M: Visual function, blood pressure and blood glucose in diabetic patients undergoing continous ambulatory peritoneal dialysis. Proc Europ Dial Transpl Ass 21: 330–334, 1984.
Ramsay RC, Cantrill H, Knoblooch W, Comty CM, Najarian JS, Goetz FC: Visual status in diabetic patients following therapy for end stage nephropathy. In: Friedman E and l’Espereance F (eds), Diabetic Renal-Retinal Syndrome 3. Grüne and Stratton, New York, 3: 443–451, 1986.
Kohner E, Chahal P: Retinopathy in diabetic nephropathy. In prevention and treatment of diabetic nephropathy. Lancaster, MTP Ltd, pp. 191–196.
Diaz-Buxo JA, burgess WP, Greenman M, Chandler JT, Farmer CD, Walker PJ: Visual function in diabetic patients undergoing dialysis: comparison of peritoneal and hemodialysis. Int. J. Artif. Organs. 7: 257–262, 1984.
Rottembourg J, Remaoun M, Maiga K, Bellio P, Issad B, Boudjemaa A, Cossette PY: Continuous ambulatory peritoneal dialysis in diabetic patients. The relationship of hypertension to retinopathy and cardiovascular complications. Hypertension (Suppl 2,) 7: 125–130, 1985.
Sutherland DE, Morrow CE, Fryd D, Ferguson R, Simmons R, Najarian JS: Improved patient and primary renal allograft survival in uremic diabetic recipients. Transplantation 34: 319–325, 1982.
Brown PM, Johnston KW, Fenton SSA, Cattran DC: Symptomatic exacerbation of peritoneal vascular disease with chronic ambulatory peritoneal dialysis. Clin Nephrol 16: 258–261, 1981.
Rottembourg J, Kahn JF, Mehamha H, Brouard R: Peripheral vascular disease in diabetic and non diabetic patients on CAPD. Perit Dial Bull S2, 65, 1986.
Rausher H, Levitz CS, Butt KMH, Friedman E: Podiatric contribution to limb preservation in diabetic renal transplant recipients. In: Friedman E, l’Espereance A (eds), Diabetic Renal Retinal Syndrome 2. New York, Grüne and Stratton, pp 419–426, 1982.
Ger R: Saving lost feet. In: Friedman E, l’Esperance F (eds), Diabetic Renal Retinal Syndrome 3. Grüne and Stratton, New York, 3: pp 119–130, 1986.
Abraham G, Zlotnik M, Ayiomamitis A, Oreopoulos DG: Drop out of diabetic patients from CAPD. In: Khanna R, Nolph KD, Prowant B, Twardowski Z, Oreopoulos DG (eds), Advances in Continuous Ambulatory Peritoneal Dialysis. Perit Dial Bull Inc Toronto, 7: pp 199–204, 1987.
Disney APS: Review of survival by treatment of diabetic nephropathy patients in Australia and New Zealand 1978–1984. Diabetic Nephropathy 4: 183–188, 1985.
Nolph KD, Steinberg S, Cutler SJ, Novak JW: Diabetic nephropathy and the CAPD registry. Diabetic Nephropathy 4: 161–162, 1983.
Diaz-Buxo JA, Walker PJ, CD, Chandler JT, Holt KL, Cox P: Continuous cyclic peritoneal dialysis. Trans Amer Soc Artif Int Organs 27: 51–53, 1981.
Nolph KD: Personnal communication.
Diaz-Buxo J, Walker P, Farmer C, Chandler J, Burgess W, Holt K: Diabetic nephropathy experience with various dialytic therapies. Contemp Dialysis 4: 9–13, 1983.
Diaz-Buxo J, Chandler JT, Farmer CD, Walker P, Holt KL, Burgess WP, Orr SL: Long term observation of peritoneal clearances in patients undergoing peritoneal dialysis. ISAO Journal 6: 21–25, 1983.
Goldberg M, Baugham KB, Wombolt DG: Home intermittent peritoneal dialysis in high risk patients. In: Gahl G, Kessel M, Nolph K (eds), Advances in Peritoneal Dialysis. Amsterdam, Excerpta Medica, pp 138–143, 1981.
Mion C: Integration of peritoneal dialysis in a regional and stage renal disease programme: a French experience in Languedoc-Roussillon. In: Atkins C, Thomson N, Farell P (eds), Peritoneal Dialysis. Edinburgh, Churchill Livingstone, pp 395–403, 1981.
Mion C, Slingeneyer A, Canaud B, Mourad G: Optimized dialytic therapy for insulin dependent diabetics. In: Friedman EA and L’Esperance FA (eds), Diabetic Renal-Retinal Syndrome 3. Grüne and Stratton, pp 383–402, 1986.
Twardowski ZJ, Nolph KD, Khanna R, Gluck Z, Prowant BP, Ryan LP: Daily clearances with continuous ambulatory peritoneal dialysis and nightily peritoneal dialysis. Trans Am Soc Artif Intern Organs 32: 575–580, 1986.
Twardowski ZJ, Nolph KD, Khanna R, Prowant BF, Ryan LP, Moore HL, Nielsen MP: Peritoneal equilibration test. Perit Dial Bull 7: 138–147, 1987.
Farrell PC, Randerson DH: Comparison of CAPD with HD and IPD. In: Gahl G, Kessel M, Nolph K (eds), Advances in Peritoneal Dialysis. Excerpta Medica, Amsterdam, pp 131–137, 1981.
Slingeneyer A, Mion C, Despaux E, Perez C, Duport J, Dansette AM: Use of a bacteriologie filter in the prevention of peritonitis associated with peritoneal dialysis: Long term clinical results in intermittent and continuous ambulatory peritoneal dialysis. In: Atkins RC, Thompson NP, Farrel PC (eds), Peritoneal Dialysis. Churchill Livingstone, Edinburgh, pp 301–312, 1981.
Jervell J, Brekke I, Fauchald P, Flatmark A: The management of uremia in diabetic nephropathy. Diabetic Nephropathy, 5: 52–54, 1986.
Legrain M, Rottembourg J, Bentchikou A, Strippoli P: The treatment of renal failure in diabetic patients. The best buy. In: Keen H, Legrain M (eds), Prevention and Treatment of Diabetic Nephropathy. MTP Ltd, Lancaster, pp 361–376, 1983.
Legrain M, Rottembourg J, Jacobs C: Traitement par dialyse et transplantation de l’insuffisance rénale chronique du diabétique. Diabete et métabolisme 11; 51–69, 1985.
Legrain M, Rottembourg J, Frantz Ph, Luciani J: Dialyse et transplantation chez le diabétique. La recherche du meilleur choix thérapeutique. In: Chatelain C, Legrain M (eds), Séminaires d’Uro Néphrologie Pitié-Salpétrière 11. Masson, Paris, pp 71–89, 1985.
Migliori RL, Simmons RL, Payne WD, Ascher NL, Sutherland DER, Najarian JS, Fryd D: Renal transplantation done safely without prior chronic dialysis therapy. Transplantation 43: 51–55, 1987.
Mousson C, Tanter Y, Chalopin JM, Rifle G: Programme dialyse péritonéale continue ambulatoire transplantation rénale chez la diabétique insulino-dependent au stade terminal de l’insuffisance rénale. Néphrologie 8: 205–210, 1987.
Najarian JS, Sutherland DER: Optimizing renal transplantation in diabetics. In: E. Friedman, L’Esperenace F (eds), Diabetic Renal Retinal Syndrome 3. Grüne and Stratton, New York, 1986, 3: pp 111–118.
Oreopoulos D: Peritoneal membrane: handle with care. Perit Dial bull 3: 111–113, 1983.
Diaz-Buxo JA: Clinical management of the diabetic patient: the role of continuous peritoneal dialysis. In: Khanna R, Nolph KD, Prowant B, Twardowski Z, Oreopoulos DG (eds), Advances in Continuous Ambulatory Peritoneal Dialysis, 6: pp 31–38, 1986.
Mejia G, Zimmerman SW: Comparison of continuous ambulatory peritoneal dialysis and hemodialysis for diabetics. Perit Dial Bull 5: 7–11, 1985.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers
About this chapter
Cite this chapter
Rottembourg, J. (1989). Peritoneal Dialysis in Diabetics. In: Nolph, K.D. (eds) Peritoneal Dialysis. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1085-0_18
Download citation
DOI: https://doi.org/10.1007/978-94-009-1085-0_18
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6978-6
Online ISBN: 978-94-009-1085-0
eBook Packages: Springer Book Archive